| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |